About the programme
Funds one high-risk development step for academically led translational projects, such as prototype testing, biomarker validation or hit expansion. Applicants must already have explored a concept and generated preliminary data. Projects must address one goal rather than multiple work packages. Uninvited resubmissions of applications submitted after 1 April 2026 will be rejected. International research organisations cannot lead applications.
Eligibility
- Sign in to check these against your background.
How to apply
- Start application via UKRI link
- Contact MRC for resubmission or eligibility questions
Applications are submitted on Medical Research Council (MRC) / UKRI’s own site. OpenDoors helps you prepare; it is not the official application portal.
From people who applied
No notes yet.
Source and verification
- Official source
- UKRI funding opportunities
- Last checked
- 18 Nov 2026, read automatically from the official page
- Recently changed
- Eligibility updated
Run this programme? Update this listing.